id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-338597-aq80vius	Baniandrés-Rodríguez, O.	Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis	2020-10-26		.txt	text/plain	1962	147	57	The BIOBADADERM project is promoted by the Fundación Piel Sana Academia Española de Dermatología y Venereología, which receives financial support from the Spanish Medicines and Health Products Agency (Agencia Española de Medicamentos y Productos Sanitarios) and from pharmaceutical companies (Abbott/Abbvie, Almirall, Janssen, Leo Pharma, Lilly, Novartis and UCB). • Dr Sahuquillo has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Celgene, Janssen-Cilag, LEO Pharma, Lilly, Novartis and Pfizer. The main analysis examined hospitalization, ICU and death in PCR-confirmed patients included in Biobadaderm as compared to PCR-confirmed cases published by the Spanish Ministry of Health [2] . • Dr Herrera-Ceballos has served as a consultant and/or speaker for and/or participated in clinical trials as IP and sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Janssen-Cilag, LEO Pharma, Lilly, Novartis and Pfizer.	./cache/cord-338597-aq80vius.txt	./txt/cord-338597-aq80vius.txt